Navigation Links
Agar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences

ProductsAgar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences
Company GE Healthcare, formerly Amersham Biosciences
Item Agar (BACTERIOLOGICAL GRADE)
Price $317.00
Description Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals .
Info GE Healthcare, formerly Amersham BiosciencesGE Healthcare, formerly Amersham Biosciences
800 Centennial Avenue
PO Box 1327
Piscataway, NJ 08855-1327
USA


For GE Healthcare contacts in other countries
please click here.


Call GE Healthcare, formerly Amersham Biosciences to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-461-9198
Customer Service: 732-457-8000
Fax Number: 732-235-2201
Web Site: http://www.gelifesciences.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Taq DNA Polymerase (cloned) from GE Healthcare, formerly Amersham Biosciences
2. Taq DNA Polymerase (Thermus aquaticus) from GE Healthcare, formerly Amersham Biosciences
3. Taq DNA Polymerase (Thermus aquaticus) from GE Healthcare, formerly Amersham Biosciences
4. One-Phor-All Buffer PLUS from GE Healthcare, formerly Amersham Biosciences
5. Ready-To-Go T4 DNA Ligase from GE Healthcare, formerly Amersham Biosciences
6. CodeLink Activated Slides from GE Healthcare, formerly Amersham Biosciences
7. Cell Proliferation Kit from GE Healthcare, formerly Amersham Biosciences
8. Zebrafish Vitellogenin ELISA System from GE Healthcare, formerly Amersham Biosciences
9. Carp Vitellogenin ELISA System from GE Healthcare, formerly Amersham Biosciences
10. Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead from GE Healthcare, formerly Amersham Biosciences
11. Human MMP-3 Assay Kit from GE Healthcare, formerly Amersham Biosciences
Anti-G Protein Gi-alpha-1 Monoclonal Antibody, Unconjugated, Clone R4 from CHEMICON
Anti-VEGF Receptor-2 (FLK-1, KDR), phospho (Tyr996) Antibody, Unconjugated from CHEMICON
Rat IgG2b Clone: A95-1, Allophycocyanin Conjugated/Tagged from BD Biosciences Pharmingen
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Biology Products:
(Date:12/2/2009)...a cancer-free status did not prompt people partici... lung-cancer screening program to pick up their ci...shed in Cancer Epidemiology, Biomarkers & Prevent...ncer Research. The December issue contains a speci...ate widespread concern in the lung screening commu...
(Date:12/2/2009)...eanut butter, and other foods have done more than ...ty. They also are quietly fueling a boom in the ma...food safety regulations. That,s the topic of the t...cal & Engineering News , (C&EN) ACS, weekly newsma...and Senior Correspondent Marc Reisch point out tha...
(Date:12/2/2009)...of undergraduate students from Stevens Institute o...poster contest hosted by the International Society...nual contest highlights the research conducted by ...nnual Meeting in San Diego, Calif. , The winning...e Ligament Tensioning Device," was presented by Aa...
Breaking Biology News(10 mins):Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Delcath Systems Announces Completion of Public Offering 6385 1Delcath Systems Announces Completion of Public Offering 6385 2Scientists find molecular trigger that helps prevent aging and disease 61643 1Scientists find molecular trigger that helps prevent aging and disease 61643 2Scientists find molecular trigger that helps prevent aging and disease 61643 3New on off switch triggers and reverses paralysis in animals with a beam of light 10798 1
...ns Hopkins researchers have found that two genes a...ded for proper cell division. They report their fi... The researchers discovered that the two genes are..., raising the possibility that interfering with th...ell division found in cancers. Mutations in the ge...
...anoma is a particularly deadly form of skin cancer...e Moffitt Cancer Center & Research Institute a...romising new therapy that prompts the immune syste...This is a milestone clinical trial because it is t...o deliver plasmid DNA in a gene therapy study in h...
...ce 1976 the Ebola virus has caused some lethal hum...ates that humans do not become directly contaminat... still unknown, but from infected carcasses of chi...esults have come from work conducted over the past...s (1) to shed light on the virus,s propagation pat...
Other Biology News:Pair of cancer genes found to drive both cell migration and division 2Researchers test new therapy for advanced melanoma 2Ebola virus: from wildlife to dogs 2Ebola virus: from wildlife to dogs 3Ebola virus: from wildlife to dogs 4
(Date:12/2/2009)...-Asia/ -- The world is going through,extraordinary...part of many,businesses and industries. It turns o...mune to the economic downturn, because illness doe...of the difficult times this year, the pharmaceutic...p;D center in Shanghai, the largest of,its kind in...
(Date:12/1/2009)...swire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nas...the fourth quarter ended December 31, 2009 of appr...n for the fourth quarter of 2008. Included in four...llment payments of $12.5 million from Alexion. Al...ne-time $1.8 million payment from Genentech for th...
(Date:12/1/2009).../ -- Harvest Technologies Corp. ( www.harvesttech....nsored 60-patient clinical trial conducted at Sri ... the company,s BMAC System to treat patients with ...Sri Ramachandra Medical Center is a Harvard Medica...ennai, India and one of the largest private health...
(Date:12/1/2009)...e/ -- Expanding its European reach for bacterial p...ppointed Lake Chemicals and Minerals of England as...gham, England. ,, Osprey breeds trillions of b...aste water, and environmental markets. Its bacteri...and clean up industrial and marine spills. In agri...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3